Check your cabinets. Another common medication is being recalled.
The FDA has recalled more than 11,000 bottles of a widely used blood pressure medication after the pills failed to meet dissolution specifications, meaning they may not work as intended.
What’s Recalled and Why
The nationwide recall covers 11,460 bottles of Chlorthalidone tablets, USP, 25 milligrams, in both 100-tablet and 1,000-tablet bottles. The affected batches are RISA24001 and RISB24002, with an expiration date of April 2027. The recall was classified as Class II by the FDA, meaning the use of the product may cause temporary or medically reversible adverse health consequences.
Dissolution testing measures how well a drug dissolves and releases into the body. When a medication fails those specifications, it may not deliver the correct dosage—reducing its effectiveness and carrying the potential to leave a patient undertreated.
Chlorthalidone is used to treat high blood pressure, a condition affecting the body’s arteries that can lead to serious cardiovascular complications if left unmanaged.
The pills were manufactured by Inventia Healthcare Limited in India and distributed by Rising Pharma Holdings, Inc. in East Brunswick, New Jersey. The recall was voluntarily initiated by the firm on June 5 and classified by the FDA on June 22.
Patients who have bottles from the affected batches should contact their pharmacist or physician. The recall comes roughly a month after a separate blood pressure medication was recalled in May.
The New Jersey Digest is a new jersey magazine that has chronicled daily life in the Garden State for over 10 years.